From professional translators, enterprises, web pages and freely available translation repositories.
antihiperglucemiantes:
antihypoglycemics:
Last Update: 2012-09-09
Usage Frequency: 1
Quality:
antihiperglucemiantes orales biguanidas
biguanide oral antihyperglycemics
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
uso con otros medicamentos antihiperglucemiantes e hipoglucemia
use with other antihyperglycaemic medicinal products and hypoglycaemia
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dulaglutida posee distintas acciones antihiperglucemiantes del glp-1.
dulaglutide exhibits several antihyperglycaemic actions of glp-1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hipoglucemia cuando se usa en combinación con otros medicamentos antihiperglucemiantes
hypoglycaemia when used in combination with other anti-hyperglycaemic medicinal product
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
la metformina es una biguanida con efectos antihiperglucemiantes que reduce la glucosa plasmática basal y postprandial.
metformin is a biguanide with anti-hyperglycaemic effects, lowering both basal and postprandial plasma glucose.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
grupo farmacoterapéutico: fármacos usados en la diabetes, combinación de fármacos antihiperglucemiantes orales.
pharmacotherapeutic group: drugs used in diabetes, combinations of oral blood glucose lowering drugs.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
grupo farmacoterapéutico: fármacos usados en diabetes, otros fármacos antihiperglucemiantes, excluidas las insulinas.
pharmacotherapeutic group: drugs used in diabetes, other blood glucose lowering drugs, excluding insulins.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
metformina metformina es una biguanida con efectos antihiperglucemiantes que disminuye la glucosa plasmática basal y post-prandial.
metformin metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
tracto gastrointestinal y metabolismo) la metformina es una biguanida con efectos antihiperglucemiantes, que reduce la glucosa en plasma posprandial y basal.
gastrointestinal tract and metabolism) metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
januvia pertenece a una clase de antihiperglucemiantes orales que se denominan inhibidores de la dipeptidil-peptidasa 4 (dpp-4).
januvia is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (dpp-4) inhibitors.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
competact combina dos principios activos antihiperglucemiantes con mecanismos de acción complementarios para mejorar el control glucémico en pacientes con diabetes mellitus tipo 2: pioglitazona, perteneciente a la clase de las tiazolidinadionas y el hidrocloruro de metformina, perteneciente a la clase de las biguanidas.
competact combines two antihyperglycaemic active substances with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes mellitus: pioglitazone, a member of the thiazolidinedione class and metformin hydrochloride, a member of the biguanide class.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hipoglucemia cuando se usa en combinación con otros medicamentos antihiperglucemiantes en los ensayos clínicos de januvia en monoterapia y en terapia combinada con medicamentos con un efecto hipoglucemiente no conocido (p. ej., metformina o pioglitazona), los índices de hipoglucemia notificados con sitagliptina fueron similares a los índices de los pacientes tratados con placebo.
hypoglycaemia when used in combination with other anti-hyperglycaemic agents in clinical trials of januvia as monotherapy and as part of combination therapy with agents not known to cause hypoglycaemia (i. e. metformin or pioglitazone), rates of hypoglycaemia reported with sitagliptin were similar to rates in patients taking placebo.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.